The Th1 to Th2 shift induced by Schistosoma mansoni does not exacerbate murine aids (MAIDS)

被引:6
作者
Lacroix, C [1 ]
Akarid, K
Chau, F
Sinet, M
Verola, O
Carbon, C
Derouin, F
机构
[1] Hop Bichat Claude Bernard, INSERM, U13, F-75877 Paris 18, France
[2] Hop St Louis, Lab Parasitol Mycol, Paris, France
[3] Hop St Louis, Lab Anatomopathol, Paris, France
关键词
Schistosoma mansoni; murine AIDS; LP-BM5; co-infection;
D O I
10.1046/j.1365-3024.1998.00186.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Schistosoma mansoni infection in mice is associated with a switch from a Th1 to a Th2-type cytokine response. The role of Th1 and Th2 responses in immune dysregulations associated with AIDS and murine AIDS (MAIDS) is controversial, bur a Th2 bias could be associated with disease progression, raising the hypothesis that helminth infections might accelerate the retroviral disease progression. Here, we used the murine model of AIDS to evaluate the course of the viral disease during co-infection with S. mansoni, C57BL/6 mice were infected with S. mansoni cercariae S weeks before intravenous challenge with the LP-BM5 retroviral complex. MAIDS did not progress faster in co-infected mice, in terms of spleen and inguinal lymphadenopathy size, ecotropic vine titres in the spleen, or in vitro proliferative responses to mitogen. Th2 cytokine production was not enhanced in co-infected animals, except for an isolated increase in IL-4 production 21 weeks after LP-BM5 injection. Co-infected animals had significantly lower lymph node and spleen weights than mice infected with LP-BM5 only. MAIDS did not influence the granulomatous response to S. mansoni in the liver of co-infected mice. Finally, infection with S. mansoni neither enhanced Th2 cytokine production nor accelerated MAIDS progression in animals subsequently challenged with LP-BM5,
引用
收藏
页码:497 / 501
页数:5
相关论文
共 19 条
[1]   INCREASED SUSCEPTIBILITY OF MICE INFECTED WITH SCHISTOSOMA-MANSONI TO RECOMBINANT VACCINIA VIRUS - ASSOCIATION OF VIRAL PERSISTENCE WITH EGG GRANULOMA-FORMATION [J].
ACTOR, JK ;
MARSHALL, MA ;
ELTOUM, IA ;
BULLER, RML ;
BERZOFSKY, JA ;
SHER, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3050-3056
[2]  
AKARID K, 1995, EUR CYTOKINE NETW, V6, P181
[3]   Th1-Th2: reliable paradigm or dangerous dogma? [J].
Allen, JE ;
Maizels, RM .
IMMUNOLOGY TODAY, 1997, 18 (08) :387-392
[4]   RAPID CELL CULTURE ASSAY TECHNIQUE FOR MURINE LEUKAEMIA VIRUSES [J].
BASSIN, RH ;
TUTTLE, N ;
FISCHINGER, PJ .
NATURE, 1971, 229 (5286) :564-+
[5]   IMMUNE ACTIVATION IS A DOMINANT FACTOR IN THE PATHOGENESIS OF AFRICAN AIDS [J].
BENTWICH, Z ;
KALINKOVICH, A ;
WEISMAN, Z .
IMMUNOLOGY TODAY, 1995, 16 (04) :187-191
[6]   IMMUNITY TO SCHISTOSOMES [J].
CAPRON, AR .
CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) :419-424
[7]   THE TH1-TH2 HYPOTHESIS OF HIV-INFECTION - NEW INSIGHTS [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1994, 15 (12) :575-581
[8]   MURINE AIDS - A MODEL FOR THE HUMAN-DISEASE OR A DISTINCT ENTITY [J].
CUNNIGHAM, RK ;
THACORE, HR ;
ZHOU, P ;
TERZIAN, R ;
NAKEEB, S ;
ZALESKI, MB .
IMMUNOLOGIC RESEARCH, 1994, 13 (01) :21-28
[9]   EVIDENCE THAT CYTOKINE-MEDIATED IMMUNE INTERACTIONS INDUCED BY SCHISTOSOMA-MANSONI ALTER DISEASE OUTCOME IN MICE CONCURRENTLY INFECTED WITH TRICHURIS-MURIS [J].
CURRY, AJ ;
ELSE, KJ ;
JONES, F ;
BANCROFT, A ;
GRENCIS, RK ;
DUNNE, DW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :769-774
[10]   MODULATION OF SPECIFIC T-CELL RESPONSES BY CONCURRENT INFECTION WITH LEISHMANIA-MAJOR AND LP-BM5 MURINE LEUKEMIA VIRUSES [J].
DOHERTY, TM ;
MORSE, HC ;
COFFMAN, RL .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (01) :131-138